Warthausen, Germany

Stefan Scheuerer

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 7.9

ph-index = 6

Forward Citations = 76(Granted Patents)


Location History:

  • Warthausen, CZ (2014)
  • Biberach an der Riss, DE (2022)
  • Warthausen, DE (2009 - 2023)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: The Innovative Contributions of Stefan Scheuerer in Medicinal Research

Introduction: Stefan Scheuerer, based in Warthausen, Germany, is a notable inventor with an impressive portfolio comprising 25 patents. His groundbreaking work primarily focuses on the development of novel therapeutic compounds, specifically targeting innovative treatments for pulmonary diseases.

Latest Patents: One of Scheuerer's most recent patents is centered around CCR2 receptor antagonists and their applications in medicine. This invention elucidates the potential of these antagonists in creating medications that specifically target and treat various medical conditions, particularly pulmonary diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The implications of these discoveries could significantly enhance treatment efficacy for affected patients.

Career Highlights: Throughout his career, Stefan Scheuerer has contributed his expertise to prominent companies including Boehringer Ingelheim International GmbH and Centrexion Therapeutics Corporation. His tenure at these organizations has been pivotal in advancing research aimed at improving health outcomes through innovative drug development.

Collaborations: Scheuerer has had the opportunity to collaborate with fellow researchers and professionals in the field, such as Christoph Hoenke and Sara Frattini. These partnerships have been instrumental in driving forward his research initiatives and expanding the impact of his inventions.

Conclusion: Stefan Scheuerer exemplifies the innovative spirit of modern inventors, particularly in the pharmaceutical sector. With his extensive patent portfolio and commitment to addressing complex health issues, his contributions are likely to leave a lasting impact on the medical community and the lives of patients battling pulmonary diseases. The ongoing evolution of his work promises to further advance the frontier of medicinal research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…